These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2655692)

  • 21. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
    Ballantyne D; Ballantyne FC; McMurdo
    Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.
    Harper R; Ennis CN; Heaney AP; Sheridan B; Gormley M; Atkinson AB; Johnston GD; Bell PM
    Diabetologia; 1995 Jul; 38(7):853-9. PubMed ID: 7556989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs.
    Waal-Manning HJ; Simpson FO
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():379s-382s. PubMed ID: 396085
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
    J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.
    Weber MA; Mansfield TA; Cain VA; Iqbal N; Parikh S; Ptaszynska A
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):211-220. PubMed ID: 26620248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
    Hansen M; Hansen OP; Lindholm J
    Acta Med Scand; 1977; 202(5):385-8. PubMed ID: 335794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    S Afr Med J; 1977 Apr; 51(14):461-3. PubMed ID: 860171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    Curr Med Res Opin; 1977; 4(9):627-9. PubMed ID: 590023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
    Grimm RH; Flack JM; Schoenberger JA; Gonzalez NM; Liebson PR
    Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 37. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S; Norris RJ
    J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
    Pollare T; Lithell H; Berne C
    N Engl J Med; 1989 Sep; 321(13):868-73. PubMed ID: 2671740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of antihypertensive therapy with a calcium antagonist.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; DiPette DJ; Evans RR
    Am J Cardiol; 1988 Oct; 62(11):109G-113G. PubMed ID: 3051991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.